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During the process of biological nitrogen fixation, the enzyme nitrogenase catalyzes the ATP-dependent reduction of dinitrogen to
ammonia. Nitrogenase consists of two component metalloproteins, the iron (Fe) protein and the molybdenum-iron (MoFe) protein;
the Fe protein mediates the coupling of ATP hydrolysis to interprotein electron transfer, whereas the active site of the MoFe protein
contains the polynuclear FeMo cofactor, a species composed of seven iron atoms, one molybdenum atom, nine sulfur atoms, an
interstitial light atom, and one homocitrate molecule. This Perspective provides an overview of biological nitrogen fixation and
introduces three contributions to this special feature that address central aspects of the mechanism and assembly of nitrogenase.
B
iological nitrogen fixation, as
defined by the reduction of di-
nitrogen to ammonia under
physiological conditions, is ther-
modynamically favorable (1). Even at
low intracellular dissolved gas pressure,
the reaction has a large negative free
energy when reduced ferredoxin (Fdred)
serves as the electron donor. Neverthe-
less, the enzymatic reaction, as catalyzed
by the complex metallocluster-
containing nitrogenase system, does not
proceed without the additional input of
substantial quantities of energy in the
specific form of ATP hydrolysis. These
requirements may be summarized by the
following equation:
N2 8 H 8 Fdred nATP3
2NH3 H2 8 Fdox nADP nPi,
[1]
where n is the ratio of ATP hydrolyzed
per electron transferred. This expression
encompasses three central questions rel-
evant to the mechanism of nitrogenase:
What is the role of nucleotide hydrolysis
in electron transfer and substrate
reduction?
How are substrates bound and reduced at
the active site?
How are the nitrogenase metalloclusters
assembled and inserted?
These issues are addressed in the contri-
butions to this Nitrogen Fixation Special
Feature by the groups of Watt (2);
Seefeldt, Dean, and Hoffman (3); and
Ribbe, Hodgson, and Hedman (4). The
purpose of this Perspective is to provide
both a background for these contribu-
tions and a summary of our views on
the progress made in deciphering the
molecular mechanisms of this fascinat-
ing process.
Intermolecular Electron Transfer and the
Role of ATP Hydrolysis in Nitrogenase
The overall reaction mechanism of biolog-
ical nitrogen fixation (Eq. 1) may be di-
vided into two parts (5, 6): (i) the control
or regulation of electron transfer to the
substrate reduction site and (ii) the sub-
strate reduction process itself. What sets
nitrogenase apart from essentially all
other enzymatically catalyzed redox pro-
cesses is the number of electrons (eight)
that must ultimately be delivered to the
substrates each turnover cycle, with the
consequent demand for precise timing of
the underlying electron transfer events.
The first part of this mechanism consists
of a cycle involving the ATP-dependent
electron transfer between the two protein
components of nitrogenase, named Fe
protein and MoFe protein, as diagram-
matically shown in Scheme 1. The second
part of the process, discussed subse-
quently, involves substrate reduction on
the MoFe protein when sufficient cycles
of intermolecular electron transfer have
occurred.
In this first cycle, the transfer of elec-
trons from the Fe protein to the MoFe
protein has an obligatory requirement
for ATP hydrolysis by the Fe protein,
which occurs only in the complex. Es-
sential features of the electron transfer
and ATP hydrolysis processes (Figs. 1
and 2), most notably the structures of
the constituent metalloclusters and the
nucleotide-binding site, have been de-
fined by high-resolution x-ray crystal
structures of the component proteins
(7–15). In addition to the individual
proteins, structures of complexes be-
tween Fe protein and MoFe protein
have also been obtained at moderate
resolutions (16–19) that correspond to
several of the putative intermediates
indicated in Scheme 1.
The Fe protein is a homodimeric pro-
tein with a [4Fe:4S] cluster that bridges
the two subunits (20). Although tradi-
tional in structure (Fig. 1A), this cluster
has the unique property of undergoing
reversible redox reactions between three
oxidation states (21), unlike classical
[4Fe:4S] clusters that use only two states
(22, 23).
2Fe2:2Fe3:4S227
3Fe2:1Fe3:4S2174Fe2:4S20
[2]
Most enzymological studies of nitrogenase
have used dithionite as the immediate
Fe-protein reductant. Dithionite-reduced
Fe protein is well established to exhibit
the 1 oxidation state of the cluster and
to serve as a single electron donor to the
MoFe protein in Scheme 1. As Watt and
coworkers discuss in their article (2), if
the Fe protein is reduced to the all fer-
rous 0 state during turnover, each cycle in
Scheme 1 could potentially function in the
transfer of two electrons to the MoFe pro-
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Scheme 1. Kinetic scheme depicting ATP-
dependent electron transfer between the compo-
nent proteins of nitrogenase. Av1 and Av2 denote
the MoFe protein and Fe protein, respectively,
from Azotobacter vinelandii. The superscripts R
andOx denote reduced and oxidized states of Av2,
and the superscripts N and N-1 indicate the oxida-
tion levels ofAv1beforeandafter electron transfer
from Av2. Fld, flavodoxin.
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tein (24). This could have profound con-
sequences for both doubling the specific
activity and providing an ATPe ratio of
1, rather than the presently accepted value
of 2 for a single electron transfer (exclud-
ing uncoupling processes). It is this uncer-
tainty that is reflected in the unspecified
value for ‘‘nATP’’ indicated in Eq. 1. Watt
et al. present evidence that the Azoto-
bacter flavodoxin is a sufficiently strong
reductant to produce an all-ferrous state
of the Fe protein [intriguingly, a distinct
all-ferrous form of this protein has also
been described (25)]. If this state is physi-
ologically relevant, then the nitrogenase
redox cycle in Scheme 1 could be a two-
electron process in vivo, at least when fla-
vodoxin is the Fe-protein electron donor.
Three other properties of Fe protein
should be noted for our discussion.
First, the protein has the peptide fold
and nucleotide-binding domain similar
to the G protein family of nucleotide-
dependent switch proteins (26). These
parallels are reflected through numer-
ous examples of the differential effects
of ATPADP on Fe-protein properties
such as EPR spectra, iron chelation, and
reduction potential. Second, ATP hydro-
lysis coupled to electron transfer is
required for substrate reduction. Nucle-
otide analogs that induce the switch
properties of the free Fe protein, never-
theless, do not support substrate reduc-
tion with the MoFe protein (27, 28).
Third, the Fe protein is the only known
functional electron transfer agent for
substrate reduction. The metal centers
in the MoFe protein can be reversibly
oxidized by small electron-transfer pro-
teins such as ferredoxins, f lavodoxins,
and plastocyanin or agents such as re-
dox dyes (29), but none of these can
drive substrate reduction, even if they
have a lower Eo
 than Fe protein. That
is, only Fe protein can reduce MoFe
protein beyond a level obtained by other
reductants.
The heterotetrameric MoFe protein is
composed of two copies of the homolo-
gous - and -subunits, ()2; each 
pair coordinates two unique metallo-
clusters, the FeMo cofactor and the P
cluster (Fig. 1 B and C), based on iron-
sulfur cluster motifs. Because the two
sets of clusters are separated by 70 Å
(30), each  pair likely represents the
functional unit for electron transfer and
substrate reduction. The [8Fe:7S] P clus-
ter (Fig. 1C) is positioned at the –-
subunit interface along the pseudo two-
fold axis relating the two subunits (8).
Spectroscopic studies indicate that the P
cluster is in the all-ferrous state as iso-
lated in dithionite (31). The second
MoFe protein metallocluster also con-
tains eight metals (seven Fe and one
Mo) and is designated the FeMo cofac-
tor, because, in contrast to the P cluster,
it can be extracted from partially dena-
tured protein and inserted into cofactor-
deficient MoFe protein (32). The cofac-
tor has several remarkable properties
not previously seen in Fe:S cluster
chemistry. Whereas iron-sulfur clusters
typically have a protein side chain ligand
per metal, e.g., the cluster in Fe protein,
the FeMo cofactor has only two direct
protein ligands for the eight metals. To
complete the coordination sphere, there
are additional sulfides, an organic acid
(homocitric acid), and a core, light ele-
ment, atom (see discussion below). A
plausible oxidation state assignment
for the protein-bound FeMo cofactor
(33, 34), as isolated in dithionite, is
[1Mo4:4Fe2,3Fe3:9S2]3.
Potential steps in the cycle depicted in
Scheme 1 can be envisioned in terms of
the crystal structures of different Fe
protein–MoFe protein complexes. For
our purposes, we will limit the discus-
sion to complexes of the Azotobacter
native proteins (16, 19). Historically, the
first complex to be structurally charac-
terized (16) was the putative transition
state that was trapped during ATP hy-
Fig. 1. Ball-and-stick representation of the nitrogenase metalloclusters. Shown are the Fe-protein
[4Fe:4S] cluster (A) and the two clusters of theMoFe protein, FeMo cofactor, and the P cluster (B) assigned
to the oxidation state PN (C). The radii of all non-protein atoms have been set to 0.7 Å, and the protein
ligands are presented as black bonds. Iron, molybdenum, sulfur, carbon, oxygen, and nitrogen atoms are
colored burgundy, orange, yellow, gray, red, and blue, respectively. This figure was generated with the
program MolScript (74) from Protein Data Bank entries 2NIP, 1M1N, and 3MIN.
Fig. 2. Complex of the nitrogenase proteins stabilized by ADP-AIF4
. (Left) ADP-AlF4
-stabilized half-
complex between a Fe-protein dimer and an -subunit pair of the MoFe protein. The subunits are
depicted as C traces with the MoFe - and -subunits colored red and blue, respectively, and the
individual subunits of each Fe protein colored green and yellow. Non-protein groups are shown in a
space-filling representationusing the color schemeof Fig. 1,withfluorine andmagnesiumcoloredorange
and green, respectively. (Right) Transduction pathway coupling the nucleotide and cofactor sites in the
nitrogenase complex. This view represents a slice through the complex that includes the ADP-AlF4
,
[4Fe:4S]-cluster, P-cluster, and FeMo-cofactor sites. The side chains of Asp-129 of each Fe-protein subunit
aredepictedas space-fillingmodels to illustrate the locations of these critical residues adjacent toboth the
nucleotide and cluster sites.
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drolysis by AlF4
 (35, 36), an analogue
for the departing phosphate (Fig. 2).
This structure clearly revealed an elec-
tron transfer pathway extending from
the Fe protein through the P cluster to
the FeMo cofactor. Significantly, the Fe
protein in this complex is positioned at
a separation distance from the P cluster
shorter than possible from the simple
docking of the two native proteins.
Complex formation is facilitated by a
structural reorganization of the Fe pro-
tein such that the two subunits are
folded toward each other by a hinge
motion near the [4Fe:4S] cluster. These
changes reposition the cluster more to-
ward the Fe-protein surface, which in
turn flattens to be complementary to
the MoFe protein. Furthermore, this
structure highlighted details of the ATP
hydrolysis process and the coupling to
electron transfer, as shown in Fig. 2.
The nucleotide-binding sites are located
at the dimer interface of the Fe protein,
and the conformational change upon
complex formation with the MoFe pro-
tein repositions several Fe-protein back-
bone and side-chain elements to effect
catalytic hydrolysis of the nucleotide. Of
particular significance is the observation
that two catalytic side chains extend
across the dimer interface to the oppo-
site subunit, which helps to explain why
ATP is not hydrolyzed by Fe protein in
the absence of stabilizing MoFe protein.
Recently, three structures of com-
plexes have been determined that poten-
tially represent other steps of the cycle
(19). Although the Fe protein binds on
a single face of the MoFe protein in all
these complexes, it can occupy distinct
sites on the surface. Furthermore, the
Fe protein in each binding mode has a
different conformation correlated with
the nucleotide state. The complex in
which Fe protein has bound the nonhy-
drolyzable ATP analogue, AMPPCP, is
remarkably similar to that from AlF4

trapping in terms of positioning of the
[4Fe:4S] cluster over the P cluster, yet
the dimer interface of the Fe protein
has not closed to the same extent. In the
ADP-bound state, the Fe-protein dock-
ing site principally involves the MoFe-
protein -subunit, whereas for the
nucleotide-free Fe protein, the docking
site is primarily on the MoFe-protein
-subunit. The Fe-protein [4Fe:4S]
clusters in the latter two structures are
now positioned 5–8 Å farther away
from the P cluster than in the putative
transition-state complex.
The structural features of the com-
plexes suggest the outlines of a reaction
coordinate that may help in thinking
about Scheme 1. In Fig. 3, we have ar-
ranged along the abscissa the known
protein structures in the order they
might be expected in Scheme 1 (the
missing structure is Fe protein with
ATP). Along one ordinate is the change
in hinge angle that describes the open-
ing of the Fe protein relative to the
most closed, AlF4
-trapped, putative
transition-state model (Fig. 3 Inset). On
the other ordinate is the distance be-
tween the centroids of the Fe-protein
cluster and the P cluster observed in
various complexes (for the dissociated
proteins, this distance is a lower limit, as
indicated by the arrow).
Assuming a correlation between inter-
cofactor distance and electron transfer
rate (37, 38), only the AMPPCP com-
plex exhibits a similar close approach as
in the putative transition state of the
ADP-AlF4
 complex; the electron trans-
fer rate in the nucleotide-free or ADP
complexes would be several orders of
magnitude slower because of their
longer distances. However, electron
transfer rate governed by shortest
distance alone cannot be the overall
deciding factor for productive electron
transfer because no ATP analogue, in-
cluding AMPPCP, supports substrate
reduction (27, 28, 39). One difference
between the structures is the degree of
the Fe-protein change as measured by
hinge angle; in the AMPPCP complex,
the Fe protein remains 10–15° more
open compared with the Fe protein of
the ADP-AlF4
 complex. These two
structures may begin to separate the two
parts of the process that makes Fe pro-
tein the unique donor for MoFe protein
coupled to the nucleotide hydrolysis. We
conjecture that only during hydrolysis
does the full subunit closure and reorga-
nization occur, leading to the transition
state.
Substrate Reduction
The second major question introduced
at the beginning of this Perspective, the
substrate reduction mechanism, must
start with the redox chemistry of the
metals, as shown by model reactions for
dinitrogen reduction first suggested by
Chatt (40) for molybdenum and realized
experimentally by Schrock (41), and
more recently for iron by Peters and
coworkers (42) (Scheme 2).
As demonstrated by these studies,
many of these single-site metal-nitrogen
intermediates are feasible for either iron
or molybdenum and, in one case (41),
capable of reducing dinitrogen triple
bonds with catalytic efficiency. Never-
theless, there appears to be a chemical
imperative for the decidedly more com-
plex 7Fe:9S:Mo:homocitrate cluster of
the FeMo cofactor as the active site for
substrate reduction in biological nitro-
gen fixation. For example, against the
burden of acquiring large quantities of a
scarce metal, iron, which is highly de-
pleted in the oceanic environment, evo-
lutionary pressures have retained the
Fig. 3. Correlation between hinge angle (bars) and the distance between centroids (filled triangles) of
the [4Fe:4S] andP clusterof thenitrogenaseproteins ina seriesof statesorderedalongapotential reaction
coordination for nucleotide hydrolysis. (Inset) The hinge angle is defined by the rotation angle about an
axis along the dimer interface required to superimpose one subunit of a specified Fe-protein structure
onto a subunit of the ADP-AlF4
-stabilized Fe protein, after initially superimposing the other subunits in
these structures.
Scheme 2. Generalized Chatt-type mechanism
for the reduction of dinitrogen to ammonia cata-
lyzed at a single metal accommodating oxidation
statesn ton 3. For the case ofMAMoand Fe,n
3 and 1, respectively.
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cofactor-based nitrogenase system for
more than a billion years. Even the so-
called alternate nitrogenases (43) are
believed to be a minor variant on the
cofactor theme, where the Mo is re-
placed by either V or Fe. Furthermore,
the cofactor requires the uncommon
metabolite, homocitric acid, and re-
quires 20 additional proteins for
assembly and insertion (44); the mecha-
nism of Mo and homocitrate incorpora-
tion during cofactor maturation, and the
intriguing role of the Fe protein in this
process, is detailed in two reports by
Ribbe, Hodgson, and Hedman and co-
workers (4, 45) in this special feature.
One would imagine that an active site
consisting of a simpler one- or two-
metal center for nitrogen fixation should
been evolutionarily dominant if biologi-
cally functional, yet this is not the case.
Clearly, detailed analyses of the cofac-
tor structure and chemistry are essential
for elucidating the mechanism. Thus,
when a 1.16-Å-resolution crystal struc-
ture revealed a previously undetected
electron density in the cofactor core
(19), a multitude of new questions about
the enzyme mechanism and potential
model analogues were raised. The den-
sity corresponding to this interstitial li-
gand had been obscured in previous
structures by a combination of factors
derived from resolution-dependent ter-
mination effects inherent in Fourier
analysis. It is only at resolutions beyond
1.3 Å that these effects are minimized
and the central atom could be revealed.
What is this central atom? Light ele-
ments that best fit the density are C, N,
and O; unfortunately, x-ray diffraction is
not sufficiently discriminating to distin-
guish between light elements differing
by only one to two electrons such as the
C, N, O series, and we are left with this
uncertainty in identifying the core atom.
Nevertheless, the revelation resolved a
thorny question about the iron coordina-
tion of cofactor, because this core atom
provides the fourth ligand for the trigo-
nally compressed tetrahedral coordina-
tion of the six central iron atoms.
Although the identity of this light ele-
ment cannot be unambiguously estab-
lished by crystallography, nitrogen was
marginally a better fit of the x-ray data
and intuitively more satisfying chemi-
cally. Subsequently, density functional
and other studies have been reported
(34, 46–48) incorporating the three al-
ternative light elements, to model the
electronic, magnetic, and chemical redox
properties of the FeMo cofactor. These
studies have found a preference order
N  C  O; although not proving the
element, it is suggestive of nitrogen as
the core atom. However, Seefeldt,
Dean, Hoffman, and coworkers (49, 50)
have attempted to identify the atom by
14N,15N electron-nuclear double reso-
nance (ENDOR)electron spin-echo
envelope modulation (ESEEM) spec-
troscopy and have been unable to
identify any exchangeable or non-
protein-derived N atoms associated with
the FeMo cofactor under turnover con-
ditions or in the ‘‘as isolated,’’ resting
oxidation state. These studies have con-
cluded that (i) any hypothetical core
nitrogen atom does not turn over during
catalysis and (ii) the core atom is not a
nitrogen. Although we are not being
strong advocates for a N core atom, it
seems that this spectroscopic approach
may not yet be adequate to unambigu-
ously exclude an element such as nitro-
gen that is spin-coupled in the magnetic
core, especially without a clear demon-
stration of an alternate element. (There
is a hint for a natural abundance 13C
ENDOR resonance, but its origin is not
known and the 14N resonances that are
seen have yet to be fully evaluated and
associated with any specific species or
protein residue, including the cofactor
ligand His 442.) For clusters that are
electronically complex, multielemental,
and redundant of atom type, one com-
ponent may be masked by unrecognized
properties of the system or measure-
ment process, as we found for the core
atom in the first place. For example, in
the density functional analysis of Lovell
et al. (47), the core atom is found to
have little spin density (0.02 of an
electron), which would make these spec-
troscopic features difficult to observe.
We would be less restrained and more
convinced by the ENDORESEEM re-
sults if a positive control were available
showing that model compounds, con-
taining an interstitial nitrogen atom
spin-coupled as for the cofactor, had
signature 14N ESEEMENDOR reso-
nances that are missing in the cofactor
spectrum.
Identifying the light element will re-
quire extraordinary analytical andor
spectroscopic erudition. For example,
there are 1,366 N atoms in the protein
for every potential one in the cofactor.
The numbers are even more unfavorable
for O or C. Yet this atom, we suspect,
will prove central, and not just geomet-
rically, to understanding dinitrogen, and
perhaps all substrate, reduction. The site
must certainly provide an electronic
bridge that couples the six central iron
atoms that likely serve in substrate bind-
ing and reduction. In this central loca-
tion, the ligand contribution to any
individual iron could be modulated by
redox changes at the other iron sites,
allowing incoming substrates to displace
the core ligand at one or more iron at-
oms without significant distortion of the
cluster. If the atom were nitrogen, one
appealing thought is that the atom
might be a remnant after half dinitrogen
reduction. Such a notion is less persua-
sive, however, when the energetics of
the cofactor structural rearrangement to
expose the site are considered (see refs.
48 and 51). Likewise, fully active MoFe
protein can be generated in mutant
strains of Azotobacter vinelandii that can-
not turn over substrates (52, 53). Hence,
it is probable that the core atom is in-
serted during cluster synthesis, although
this does not preclude the atom ex-
changing during catalysis.
The critical first step in elucidating
the nitrogenase mechanism, how sub-
strates or inhibitors bind to the FeMo
cofactor, is made more complicated by
the plethora of substrates reduced by
nitrogenase besides the natural sub-
strates dinitrogen and proton (see refs.
54 and 55). Most substrates and inhibi-
tors have in common a multiple bond
(with the notable exception of pro-
tons), and the atoms delineating the
bond(s) can be C, N, O, and S in vari-
ous combinations. In model com-
pounds, both end-on and side-on bind-
ing modes have been observed, and
neither mode has been excluded for
the enzyme. In addition, different sub-
strates appear to bind at different net
reduction states of the cofactor; that is,
a different number of redox cycles in
Scheme 1 are required for binding of
different substrates.
Although the distinctive structure of
the FeMo cofactor is generally appreci-
ated, how it differs from conventional
[4Fe:4S] clusters can be obscured by the
traditional ‘‘ball-and-stick’’ representa-
tions often used. For accessibility of
substrates and ligands, FeMo cofactor
depicted with nominal ionic or van der
Waals radii is more appropriate where
sulfur atoms have radii around 1.7 Å,
more than twice the ionic radii of Fe3,
Fe2 (0.7 Å) or Mo4 (0.8 Å) (56, 57)
(Fig. 4). The six central iron atoms that
lack protein ligands constitute three
4Fe:4S faces dominated by the four sul-
fur atoms. Ligands approaching a 4Fe:4S
face are restricted to the irons by the
sulfurs, especially the two axial sulfides
(separated by 5 Å), so that van der
Waals contact between an approaching
dinitrogen and the sulfurs would occur
3.4–3.8 Å from an iron. From the
direction along the Fe-central ligand
vector, dinitrogen could approach
somewhat closer (2.8 Å), but this dis-
tance is still too large to permit direct
coordination.
A comparison to the conventional
[4Fe:4S] cluster used for substrate bind-
ing and catalysis in aconitase (58) is in-
formative. Both cofactor and aconitase
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have iron sites that lack protein ligands
while remaining coordinated to three
sulfides; yet, there are significant differ-
ences in the surface geometry of these
sites (Fig. 4). For the cofactor, each
central iron atom is inside a concave
surface of sulfur atoms, whereas in ac-
onitase, the unliganded iron site pro-
trudes from the convex surface of sulfur
atoms. Indeed, a solvent molecule coor-
dinates this position in the absence of a
substrate for aconitase, indicating that
there would be no steric restrictions
for a molecule the size of dinitrogen to
approach this iron and, hence, a site
more in keeping with the bioinorganic
models.
The overall impression of the FeMo-
cofactor structure is one of steric restric-
tion to the metal sites leading to low
chemical reactivity. Both traditional
cluster and cofactor metals with protein
ligands are sterically blocked by the ter-
minal ligands, but only in the FeMo co-
factor are the metals without protein
ligands also restricted. What is particu-
larly revealing is the dominance of the
sulfur atoms in the overall topology. Re-
stricted access to the metals and low
chemical reactivity is contrary to the
expectation for the site of dinitrogen
reduction. Nevertheless, there is more
than conjecture suggesting that FeMo
cofactor has unusual chemical reactivity.
It has always seemed surprising that the
cluster could be extracted intact from
the denatured protein without added
stabilizing ligands such as thiols, as re-
quired for traditional Fe:S clusters (32).
The isolated cofactor is unexpectedly
stable with only a single iron site bound
by excess added thiols, a condition that
can lead to decomposition of simpler
clusters (59).
Outstanding Mechanistic Issues
Beyond the binding mode, any mecha-
nistic proposal must explain or consider
a number of other aspects of the system.
Briefly, these are as follow.
Order of Addition of Protons and Electrons.
The reduction vs. proton addition steps
are only superficially considered in our
representation of substrate reduction
(Scheme 2), yet how this occurs has
substantial implications. The Seefeldt,
Dean, and Hoffman collaboration of co-
workers have identified potential interme-
diates using a combination of mutant
proteins, magnetic spectroscopy, and
isotopically labeled compounds (60–64).
In this special feature (3), they present
evidence that for the substrate methyldia-
zene, only the terminal N atom binds to
an iron and that protons are added in an
alternating fashion between the two nitro-
gens with the first proton added to the
non-iron-bound nitrogen.
Origin of the Protons. Proton addition is
required for the reduction of all known
nitrogenase substrates, but it is not clear
whether the protons come from the
same donors for all substrates. For ex-
ample, acetylene reduction is stereospe-
cific (65), but the selectivity changes
with substrate concentration (66), sug-
gesting at least a change in mechanism
or mode of substrate binding where the
proton donor(s) may be different. Both
water molecules adjacent to the cofactor
and the sulfides of the cluster suggest
intriguing possibilities for the proton
donors.
Altered or Mutant Proteins. Altered pro-
teins, generated either by mutagenesis or
chemical modification, have been invalu-
able in elucidating enzyme mechanisms by
identifying potential functions of specific
amino acid residues. However, altered
activity with side-chain changes can be
structurally allosteric or compensating,
rather than providing unambiguous evi-
dence for direct side chain involvement in
the reaction, as experienced with inor-
ganic complexes (67, 68). Ultimately, the
use of any modified protein must be justi-
fied within the context of the mechanism
even when the alteration provides a route
to identifying a potential intermediate.
Role of Homocitric Acid. Homocitric acid
is required for dinitrogen reduction
(69), but other di- or tricarboxylic ac-
ids support some substrate reductions
(70), if weakly. As observed with muta-
tions in the protein structure, changes
in this ligand are difficult to explain
simply by direct effects on a localized
site. The cofactor structure and sur-
rounding environment are so complex
that changes at one site may be propa-
gated to a distant site to effect the
observed altered chemical reactivity
expressed in substrate specificity or
reduction rates.
Role of Hydrogen Evolution. In the ab-
sence of other substrates, protons are
reduced to dihydrogen that can be fully
suppressed by most other substrates. In
contrast, even at saturating dinitrogen,
protons are reduced to dihydrogen
(71). In addition, dinitrogen reduction
is inhibited by dihydrogen and medi-
ates the formation of HD from D2
(72). A description of the chemical
mechanism of dinitrogen reduction
cannot be complete without including
these unique dihydrogen reactions.
Substrate Specificity and Binding Sites. The
binding sites for substrates may be de-
fined as much by the redox state of the
cofactor as the physical site. The kinet-
ics of mixed substrates are complex
and are typically analyzed as competi-
tive, noncompetitive, and uncompeti-
tive depending on the combination of
substrates investigated (73). As noted
above, the FeMo cofactor has multiple
potential binding sites, and it would be
difficult to establish kinetic interac-
tions between these potential binding
modes. Hence, it would not be surpris-
ing if there were more than one de-
tailed mechanism depending on the
substrate; although there should be
common features, results with one sub-
strate should not uncritically be as-
signed to all.
Concerning the title question (How
many metals does it take to fix N2?), from
our perspective, the correct answer for
Fig. 4. Space-filling representation of the FeMo-cofactor (Left) and [4Fe:4S] cluster of aconitase (Right)
using chemically appropriate radii for their atoms, including theprotein side-chain ligands andhomocitric
acid. Dinitrogen is included for size comparison. The radii used to generate this figure were as follows: C,
1.5 Å; O, 1.4 Å; interstitial ligand (N3), 1.4 Å; N in N2, 1.6 Å; S, 1.7 Å; Fe, 0.7 Å; and Mo, 0.8 Å (56, 57).
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biological nitrogen fixation is 20—the
number of unique metals in the FeMo
cofactor, P cluster, and Fe protein—
because they are all needed to fix dinitro-
gen, and no one has found a way to sim-
plify this system. This then leads to the
corollary question, What are they all do-
ing? The recent progress in this field, ex-
emplified in the contributions to this spe-
cial feature, suggests that answers to these
questions will be forthcoming within the
next few years.
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